PlainRecalls
FDA Drug Moderate Class II Terminated

INVEGA SUSTENNA 156MG/1ML; NDC/UPC 50458056301; RX; SYRINGES

Reported: June 2, 2021 Initiated: March 15, 2021 #D-0498-2021

Product Description

INVEGA SUSTENNA 156MG/1ML; NDC/UPC 50458056301; RX; SYRINGES

Reason for Recall

CGMP Deviations: Intermittent exposure to temperature excursion during storage.

Details

Recalling Firm
Cardinal Health Inc.
Units Affected
534 syringes
Distribution
FL, GA, SC
Location
Dublin, OH

Frequently Asked Questions

What product was recalled?
INVEGA SUSTENNA 156MG/1ML; NDC/UPC 50458056301; RX; SYRINGES. Recalled by Cardinal Health Inc.. Units affected: 534 syringes.
Why was this product recalled?
CGMP Deviations: Intermittent exposure to temperature excursion during storage.
Which agency issued this recall?
This recall was issued by the FDA Drug on June 2, 2021. Severity: Moderate. Recall number: D-0498-2021.